Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that, through its Calando Pharmaceuticals subsidiary, it has completed enrollment of a phase 1b clinical ...
LOWELL — The Cambodian American Literary Arts Association is a new nonprofit organization in Lowell that educates and empowers the Cambodian and multicultural communities through the literary arts.
Calando Pharmaceuticals, Inc. has the issuance of U.S. Patent No. 7,427,605, entitled, “Inhibitors of ribonucleotide reductase subunit 2 and uses thereof.” The patent contains claims directed to ...
Calando Pharmaceuticals has announced that pre-clinical development of a second siRNA oncology therapeutic, CALAA-02, is underway. The intracellular target for CALAA-02 is HIF-2alpha, or Hypoxia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results